Global Respiratory Device Market 2026-2035

Description

List of Tables

Respiratory Device Market Size, Share & Trends Analysis Report by Diagnostic Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, and Others), by Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, and Others), and by Disposable Devices (Masks, Breathing Circuits, and Others), Forecast Period (2026-2035)

Industry Overview

Respiratory device market was valued at $25,909.1 million in 2025 and is projected to reach $49,914.2 million by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). The market is expanding as the prevalence of chronic respiratory conditions continues to rise globally. Companies such as ResMed Inc. and Philips Respironics are introducing advanced non-invasive devices that improve patient comfort and therapy outcomes. Increasing awareness of early diagnosis and the adoption of digital monitoring systems have strengthened the market demand. Innovations in portable oxygen systems and connectivity-enabled respiratory products are also contributing to growth. The integration of data analytics for patient monitoring is enhancing treatment accuracy and compliance. This collective development is propelling the overall market expansion.

Market Dynamics

Growing Adoption of Home-Based Respiratory Care Devices

The Global Respiratory Device Market is witnessing a steady shift toward home-based care due to the rising prevalence of chronic respiratory diseases and the increasing geriatric population. Patients prefer home-use devices such as portable oxygen concentrators, CPAP, and nebulizers for convenience and cost-effectiveness. Manufacturers are focusing on developing compact, user-friendly, and connected respiratory devices that enable remote monitoring. This transition is reducing the burden on hospitals and enhancing patient compliance. The trend reflects a broader movement toward personalized and preventive respiratory care worldwide.

Technological Advancements Enhancing Device Efficiency

Continuous innovation in respiratory technology is reshaping the market landscape. Integration of digital sensors, artificial intelligence, and IoT connectivity has improved the accuracy and efficiency of diagnostic and therapeutic devices. Smart ventilators and wearable pulse oximeters are offering real-time patient insights and facilitating proactive treatment. These innovations are being rapidly adopted across healthcare facilities and home-care settings. The focus on automation and data-driven respiratory management is expected to further strengthen market growth.

Market Segmentation

Based on the diagnostic devices, the market is segmented into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and others.
Based on the therapeutic devices, the market is segmented into CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and others.
Based on the disposable devices, the market is segmented into masks, breathing circuits, and others.

Pulse Oximeters Segment to Lead the Market with the Largest Share

The rising use of pulse oximeters for continuous oxygen level monitoring has notably supported market growth. Firms such as Masimo Corporation and Medtronic plc have introduced innovative fingertip and wearable oximeters with advanced sensor accuracy. Their adoption has increased across hospitals, clinics, and home-care setups, driven by the need for real-time oxygen saturation data. The growing popularity of compact and wireless designs has made these devices more user-friendly. In addition, integration with mobile health applications enables better patient tracking and early intervention. These developments continue to reinforce the pulse oximeter segment's dominance in the respiratory device market.

Ventilators: A Key Segment in Market Growth

The demand for ventilators remains high due to the increasing number of patients with respiratory failure and chronic lung conditions. Leading manufacturers like Dragerwerk AG & Co. KGaA and Hamilton Medical AG are developing advanced critical-care and transport ventilators that offer precise control and safety. Continuous technological upgrades have improved their functionality in both hospital and home-care environments. The introduction of compact, non-invasive ventilators has expanded their usability across diverse patient groups. Additionally, government healthcare initiatives and hospital infrastructure modernization are supporting widespread adoption. These factors collectively strengthen the global ventilator market segment.

Regional Outlook

The global respiratory device market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growing Incidence of Respiratory Disorders in Europe

The European market is witnessing growth driven by the rising incidence of respiratory disorders and expanding elderly populations. Prominent companies like Fisher & Paykel Healthcare Corporation Limited and Smiths Medical are offering advanced respiratory support systems with improved efficiency and comfort. Growing awareness of early diagnosis and preventive respiratory care has further accelerated device adoption. Government-backed healthcare programs and reimbursement support are encouraging wider use of home-based respiratory care products. The shift toward eco-friendly and energy-efficient device designs is also influencing market preferences. Together, these dynamics are shaping a steady expansion of the respiratory device market in Europe.

North America Region Dominates the Market with a Major Share

In North America, the respiratory device market is advancing rapidly owing to high healthcare expenditure and technological innovation. Companies such as Vyaire Medical Inc. and GE Healthcare Technologies Inc. are enhancing their product portfolios to meet the growing demand for efficient respiratory solutions. Increased cases of asthma, COPD, and sleep apnea are driving the need for both diagnostic and therapeutic devices. The adoption of portable and smart respiratory equipment has gained strong traction among home-care users. Hospitals are increasingly investing in AI-enabled monitoring systems for better patient outcomes. These factors are creating a favorable growth environment across the region.

Market Players Outlook

The major companies operating in the global respiratory device market include Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corp. Ltd., Medtronic plc, Philips Respironics Inc., and ResMed Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisitions strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In August 2024, Fisher & Paykel Healthcare introduced the F&P my820 System for home-based respiratory humidification in the US. The F&P my820 is the company's latest respiratory humidifier for home mechanical ventilation. The F&P my820 System provides heated humidification during the delivery of invasive ventilation, noninvasive ventilation, and humidified high-flow therapies for adult and pediatric patients.
In October 2022, AirPhysio partnered with Medsmart to bring the Australian multi-award-winning respiratory devices to India to help change people's lives. After expanding from 5 countries to over 100 in the past 2 years and helping over half a million people to improve their quality of life, AirPhysio is now available in India.

The Report Covers:

Market value data analysis of 2024 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global respiratory device market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023739

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Respiratory Device Market Sales Analysis - Diagnostic Devices | Therapeutic Devices | Disposable Devices | ($ Million)
Respiratory Device Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Respiratory Device Market Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Respiratory Device Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For Global Respiratory Device Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Respiratory Device Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - Respiratory Device Market Revenue and Share by Manufacturers
Respiratory Device Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Dragerwerk AG & Co. KGaA
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Fisher & Paykel Healthcare Corp. Ltd.
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Medtronic plc
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Philips Respironics Inc.
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. ResMed Inc.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Respiratory Device Market Sales Analysis by Diagnostic Devices ($ Million)

5.1. Spirometers
5.2. Sleep Test Devices
5.3. Peak Flow Meters
5.4. Pulse Oximeters
5.5. Capnography
5.6. Others

6. Global Respiratory Device Market Sales Analysis by Therapeutic Devices ($ Million)

6.1. CPAP Devices
6.2. BiPAP Devices
6.3. Humidifiers
6.4. Nebulizers
6.5. Oxygen Concentrators
6.6. Ventilators
6.7. Inhalers
6.8. Others

7. Global Respiratory Device Market Sales Analysis by Disposable Devices ($ Million)

7.1. Masks
7.2. Breathing Circuits
7.3. Others

8. Regional Analysis

8.1. North American Respiratory Device Market Sales Analysis - Diagnostic Devices | Therapeutic Devices | Disposable Devices | Country ($ Million)
Macroeconomic Factors for North America
- 8.1.1. United States
- 8.1.2. Canada
8.2. European Respiratory Device Market Sales Analysis - Diagnostic Devices | Therapeutic Devices | Disposable Devices | Country ($ Million)
Macroeconomic Factors for Europe
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. Italy
- 8.2.4. Spain
- 8.2.5. France
- 8.2.6. Russia
- 8.2.7. Rest of Europe
8.3. Asia-Pacific Respiratory Device Market Sales Analysis - Diagnostic Devices | Therapeutic Devices | Disposable Devices | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia & New Zealand
- 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.3.7. Rest of Asia-Pacific
8.4. Rest of the World Respiratory Device Market Sales Analysis - Diagnostic Devices | Therapeutic Devices | Disposable Devices | Country ($ Million)
Macroeconomic Factors for Rest of the World
- 8.4.1. Latin America
- 8.4.2. Middle East and Africa

9. Company Profiles

9.1. 3B Medical, Inc.
- 9.1.1. Quick Facts
- 9.1.2. Company Overview
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategies
9.2. Allied Healthcare Products Inc.
- 9.2.1. Quick Facts
- 9.2.2. Company Overview
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategies
9.3. Becton, Dickinson and Company (BD)
- 9.3.1. Quick Facts
- 9.3.2. Company Overview
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategies
9.4. Breas Medical AB
- 9.4.1. Quick Facts
- 9.4.2. Company Overview
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategies
9.5. DeVilbiss Healthcare LLC
- 9.5.1. Quick Facts
- 9.5.2. Company Overview
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategies
9.6. Dragerwerk AG & Co. KGaA
- 9.6.1. Quick Facts
- 9.6.2. Company Overview
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategies
9.7. Fisher & Paykel Healthcare Corporation Limited
- 9.7.1. Quick Facts
- 9.7.2. Company Overview
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategies
9.8. GE Healthcare Technologies Inc.
- 9.8.1. Quick Facts
- 9.8.2. Company Overview
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategies
9.9. Hamilton Medical AG
- 9.9.1. Quick Facts
- 9.9.2. Company Overview
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategies
9.10. Invacare Corp.
- 9.10.1. Quick Facts
- 9.10.2. Company Overview
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategies
9.11. Medtronic plc
- 9.11.1. Quick Facts
- 9.11.2. Company Overview
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategies
9.12. Mindray Medical International Ltd.
- 9.12.1. Quick Facts
- 9.12.2. Company Overview
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategies
9.13. Nihon Kohden Corp.
- 9.13.1. Quick Facts
- 9.13.2. Company Overview
- 9.13.3. Product Portfolio
- 9.13.4. Business Strategies
9.14. Omron Healthcare, Inc.
- 9.14.1. Quick Facts
- 9.14.2. Company Overview
- 9.14.3. Product Portfolio
- 9.14.4. Business Strategies
9.15. PARI GmbH
- 9.15.1. Quick Facts
- 9.15.2. Company Overview
- 9.15.3. Product Portfolio
- 9.15.4. Business Strategies
9.16. Philips Respironics Inc.
- 9.16.1. Quick Facts
- 9.16.2. Company Overview
- 9.16.3. Product Portfolio
- 9.16.4. Business Strategies
9.17. ResMed Inc.
- 9.17.1. Quick Facts
- 9.17.2. Company Overview
- 9.17.3. Product Portfolio
- 9.17.4. Business Strategies
9.18. Smiths Medical (ICU Medical, Inc.)
- 9.18.1. Quick Facts
- 9.18.2. Company Overview
- 9.18.3. Product Portfolio
- 9.18.4. Business Strategies
9.19. Teleflex Inc.
- 9.19.1. Quick Facts
- 9.19.2. Company Overview
- 9.19.3. Product Portfolio
- 9.19.4. Business Strategies
9.20. Vyaire Medical Inc.
- 9.20.1. Quick Facts
- 9.20.2. Company Overview
- 9.20.3. Product Portfolio
- 9.20.4. Business Strategies